The Cancer Screening Committee
- deals with questions surrounding population-based cancer screenings
- independently assesses scientific evidence and observes developments in Switzerland and abroad
- considers medical indications, epidemiological, economic, legal and ethical aspects, as well as the interests of patients
- formulates recommendations for cancer screening measures
Composition of the Committee of Experts
| Epidemiology, Methodology, Statistics | Prof. Dr. Marcel Zwahlen, Institute for Social and Preventive Medicine, University of Bern, Chairman of the Cancer Screening Committee Prof. Dr. med. Thomas Agoritsas, Divisions of Internal Medicine & Clinical Epidemiology, Geneva University Hospitals |
| Medicine (Clinical Practice and Prevention) | Prof. Dr. med. Stefan Aebi, Chief physician of medical oncology, Lucerne Cantonal Hospital Dr med. Kevin Selby, Center for Primary Care and Public Health (Unisanté), Lausanne |
| Screening | Dr. med. Jacques Fracheboud, retired, formerly Erasmus University Medical Center, Rotterdam, The Netherlands |
| Health Economics | Prof. Dr. Matthias Schwenkglenks, Institute of Pharmaceutical Medicine, University of Basel, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich |
| Ethics | Prof. Dr med. Samia Hurst-Majno, Institute for ethics, history and the humanities, University of Geneva |
| Law and Ethics | lic. iur. Michelle Salathé, Medicine Ethics Law, Basel |
| Patient partner | David U. Haerry, Chairman Positive Council, European Patients Academy (EUPATI), Zurich |